Avapag 20 mg Tablet

Description

Avapag 20 mg Tablet contains Avatrombopag, a thrombopoietin receptor agonist used to increase platelet counts in patients with chronic liver disease or chronic immune thrombocytopenia (ITP). It helps reduce bleeding risk before medical or dental procedures.

Benefits

• Helps increase platelet count safely

• Lowers risk of bleeding complications

• Reduces need for platelet transfusion

• Convenient oral once-daily dosing

• Effective alternative when other treatments fail

Indications and Usage

Avapag 20 mg Tablet is indicated for:

• Thrombocytopenia in chronic liver disease before scheduled procedures

• Chronic immune thrombocytopenia (ITP) in adults with low platelet count despite prior therapy

Not for emergency bleeding management.

How it Works

Avatrombopag activates the thrombopoietin (TPO) receptors in bone marrow, stimulating platelet production and increasing circulating platelet levels to reduce bleeding risk.

Dosage & Administration

• Dose depends on indication, platelet count & physician assessment

• Usually taken once daily with food, for the prescribed duration

• Swallow tablets whole with water

• Do not take extra doses if a dose is missed

• Requires routine platelet monitoring

Never start, adjust, or stop treatment without medical advice.

Side Effects

Common side effects:

• Headache

• Fatigue

• Nausea

• Fever

• Abdominal discomfort

Serious side effects (seek urgent care):

• Blood clots

• Severe shortness of breath or chest pain

• Liver function abnormalities

• Severe headache or neurological symptoms

Warning and Precaution

• Not recommended during pregnancy or breastfeeding unless advised

• Use cautiously in patients with history of blood clots or cardiovascular disease

• Regular liver and platelet monitoring required

• Inform doctor about ongoing medications, especially anticoagulants

• Do not use to normalize platelet count beyond target range — risk of thrombosis